Pt Phapros Tbk Sustainability Profile
PT Phapros Tbk, a prominent player in Indonesia's pharmaceutical industry, is headquartered in Semarang, Central Java. Established in 1971, the company has evolved significantly, marking key milestones in its commitment to healthcare innovation and quality. Specialising in the production of generic medicines, over-the-counter products, and herbal supplements, PT Phapros Tbk distinguishes itself through rigorous quality control and a diverse product portfolio. The company serves various regions across Indonesia, ensuring accessibility to essential healthcare solutions. With a strong market position, PT Phapros Tbk has garnered recognition for its contributions to public health, making it a trusted name in the pharmaceutical sector. Its dedication to research and development continues to drive its growth and enhance its reputation within the industry.
DitchCarbon Score
How does Pt Phapros Tbk's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pt Phapros Tbk's score of 14 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pt Phapros Tbk's reported carbon emissions
In 2023, PT Phapros Tbk reported no specific carbon emissions data, while in 2022, the company disclosed Scope 1 emissions of approximately 0.55 kg CO2e and Scope 2 emissions from purchased electricity amounting to about 10,168,000 kg CO2e. The emissions data for 2021 also showed Scope 1 emissions of about 0.5 kg CO2e and Scope 2 emissions of approximately 9,980,000 kg CO2e. The company has not set any specific reduction targets or initiatives, as indicated by the absence of documented reduction targets and SBTi commitments. Furthermore, emissions data is cascaded from its parent company, PT Kimia Farma Tbk, which may influence its overall climate strategy. PT Phapros Tbk's climate commitments remain vague, with no significant pledges or initiatives reported to date. The company operates within the pharmaceutical industry, which is increasingly under pressure to enhance sustainability practices and reduce carbon footprints.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 0.82 | 0.0 | 0.00 |
| Scope 2 | - | 0,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
How Carbon Intensive is Pt Phapros Tbk's Industry?
How Carbon Intensive is Pt Phapros Tbk's Location?
Pt Phapros Tbk's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pt Phapros Tbk has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
